Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen.
about
Evaluation of the VP22 protein for enhancement of a DNA vaccine against anthrax.Alphavirus-based vaccinesAntigen-specific immunotherapy of cervical and ovarian cancerPerspectives for preventive and therapeutic HPV vaccines.Improving DNA vaccine potency by linking Marek's disease virus type 1 VP22 to an antigenEnhancement of protein vaccine potency by in vivo electroporation mediated intramuscular injection.Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines.Expression of cutaneous lymphocyte-associated antigen by CD8(+) T cells specific for a skin-tropic virus.Approaches to enhance the efficacy of DNA vaccines.Therapeutic Vaccine Strategies against Human Papillomavirus.Emerging human papillomavirus vaccines.Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen.Generation and characterization of a preventive and therapeutic HPV DNA vaccineConnective tissue growth factor linked to the E7 tumor antigen generates potent antitumor immune responses mediated by an antiapoptotic mechanism.CpG-ODN-stimulated dendritic cells act as a potent adjuvant for E7 protein delivery to induce antigen-specific antitumour immunity in a HPV 16 E7-associated animal tumour model.Gene transfer into the central nervous system in vivo using a recombinanat lentivirus vector.Therapeutic human papillomavirus vaccines: current clinical trials and future directions
P2860
Q24795118-4ED806C9-F0EB-4E3D-8143-AC41229C5FE4Q26994724-4622DFF0-46DC-4724-9FF0-1FD10CC65CB1Q27488697-628A8CE3-F3A0-4FEF-B088-B31F38C5501DQ34011494-D52D973F-A0E5-4EBF-BFE5-610A9CDC4D29Q34332858-98718AC9-12C4-4A09-A819-14B0EF65A7F5Q34516610-BB30E22A-4AF6-4F20-A154-F7E7A5CF816EQ34703631-83E8BAA4-C9C0-4758-9FB7-27880420CA67Q34777218-63D9E4B1-5A1D-465E-BA3F-C4B9F7C4FAACQ35743279-9421C078-DDFA-4739-B51B-C2EEC76F3892Q35826752-4A81F24F-95F2-4152-BC29-8092B14DDCB5Q36066004-47666100-6EA4-47D3-9AB2-06DA4E04433FQ36167792-373D4C3B-3F79-4D69-B085-258189D90268Q36482161-5218FE35-BAB5-438F-84A1-F7F79A2BD38FQ39999888-A8F495D9-72E2-4F81-9D77-2E2F5709A50CQ47736286-3ED023AE-42FD-45DE-88FE-9567D1B8B9ECQ52124625-24BE6D03-180A-4C45-8432-6DFCF8555755Q56937332-3E7BC7D9-3D14-47D6-9D04-94ABE8933D21
P2860
Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Enhancement of Sindbis Virus S ...... Type 1 VP22 Protein to Antigen
@nl
Enhancement of sindbis virus s ...... ype 1 VP22 protein to antigen.
@ast
Enhancement of sindbis virus s ...... ype 1 VP22 protein to antigen.
@en
type
label
Enhancement of Sindbis Virus S ...... Type 1 VP22 Protein to Antigen
@nl
Enhancement of sindbis virus s ...... ype 1 VP22 protein to antigen.
@ast
Enhancement of sindbis virus s ...... ype 1 VP22 protein to antigen.
@en
prefLabel
Enhancement of Sindbis Virus S ...... Type 1 VP22 Protein to Antigen
@nl
Enhancement of sindbis virus s ...... ype 1 VP22 protein to antigen.
@ast
Enhancement of sindbis virus s ...... ype 1 VP22 protein to antigen.
@en
P2093
P2860
P1433
P1476
Enhancement of sindbis virus s ...... ype 1 VP22 protein to antigen.
@en
P2093
P2860
P304
P356
10.1128/JVI.75.5.2368-2376.2001
P577
2001-03-01T00:00:00Z